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Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and
age-related macular degeneration (AMD), share two characteristics in common:
(1) a disease prevalence that increases markedly with advancing age, and (2)
neuroinflammatory changes in which microglia, the primary resident immune cell of the
CNS, feature prominently. These characteristics have led to the hypothesis that pathogenic
mechanisms underlying age-related neurodegenerative disease involve aging changes
in microglia. If correct, targeting features of microglial senescence may constitute a
feasible therapeutic strategy. This review explores this hypothesis and its implications
by considering the current knowledge on how microglia undergo change during aging
and how the emergence of these aging phenotypes relate to significant alterations in
microglial function. Evidence and theories on cellular mechanisms implicated in driving
senescence in microglia are reviewed, as are “rejuvenative” measures and strategies that
aim to reverse or ameliorate the agingmicroglial phenotype. Understanding and controlling
microglial aging may represent an opportunity for elucidating disease mechanisms and for
formulating novel therapies.
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INTRODUCTION
As the predominant resident immune cell in the central nervous
system (CNS), microglia has been causally linked to the develop-
ment of neurodegenerative diseases in which neuroinflammation
plays a prominent role. As the prevalence of such diseases, which
include Alzheimer’s disease, Parkinson’s disease, and age-related
macular degeneration (AMD), demonstrates a strong association
with increasing age, aging changes inmicroglia have been hypoth-
esized to play a prominent role in disease pathogenesis. Over
the last few years, new and exciting discoveries with respect to
microglial physiology and function have provided key insights
that provide a conceptual framework for thinking about the con-
nection between microglial aging and neurodegenerative disease.
First, we have learned from studies employing parabiosis to create
chimerism in circulating bone-marrow derived precursors that
microglia are long-lived cells in the healthy CNS, with residence
times that extend across much of an animal’s life-span, and are
therefore susceptible to aging factors in situ (Ajami et al., 2007;
Mildner et al., 2007). Second, a critical mass of studies focused
on characterizing microglia in the aged CNS have elucidated a
combination of anatomical, morphological, physiological, and
molecular changes exhibited by agingmicroglia that now provides
a comprehensive depiction of the senescent microglial pheno-
type. Third, a combination of detailed ultrastructure studies and
live-cell imaging techniques has provided novel insights into the
constitutive cellular interactions conducted by microglia through
which the everyday functional roles of microglia can be dis-
cerned. These data allow us to conceptually connect the features
of the aging microglial phenotype with significant and conse-
quential alterations in microglial function in a way that is helpful
for thinking about mechanisms of disease pathogenesis and for
formulating strategies of disease prevention and treatment.
This review aims to summarize what is currently known
about: (1) the nature of the aging microglial phenotype, (2) how
microglial aging can impact the function of microglia in their
everyday roles, as well as in their response to perturbations, (3)
what mechanisms underlie the generation of the aging microglial
phenotype, and (4) whether aging changes in microglia may be
successfully reversed (i.e., if agedmicroglia may be therapeutically
rejuvenated).
THE AGING PHENOTYPE OF MICROGLIA
AGING CHANGES IN MICROGLIAL DENSITY, DISTRIBUTION, AND
RAMIFIED MORPHOLOGY
How do microglia in the uninjured and healthy CNS change
with aging? Microglia in the healthy young CNS have a typical
ramified morphology and are distributed throughout the neural
parenchyma in a “space-filling” manner, providing efficient spa-
tial coverage of the entire CNS milieu. This orderly arrangement
of ramified microglia reflects the presence of organizing factors
whose identity, mechanism, and purpose are still rather mysteri-
ous. Interestingly, as the CNS ages, the fidelity of these regulatory
factors appears to diminish as the numbers, distribution, and
morphological features of microglia progressively changes with
time, reflecting aging-sensitive alterations in microglia function.
The total number and density of microglia have been noted
to increase significantly with age in various CNS compartments,
including the hippocampus (Mouton et al., 2002), visual and
auditory cortices (Tremblay et al., 2012), and the retina (Damani
et al., 2011). These increases may be contributed by a low rate
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of basal microglia proliferation (Lawson et al., 1992; Ajami et al.,
2007) or otherwise a slow incremental recruitment of monocytes
or macrophages from the periphery. The significance of increas-
ing microglial numbers is unclear—one hypothesis suggests that
it may be a compensatory mechanism to maintain overall func-
tion as each individual aged microglial cell declines in function
with aging (Streit and Xue, 2010). The increase may also be driven
by a cumulative history of environmental influences (e.g., infec-
tions, injuries, inflammatory insults) that have triggered episodes
of microglial proliferation that did not fully revert back to the
basal level (Ajami et al., 2007). Currently, functional significance
of increased microglial numbers remains unknown.
With aging, the order and regularity of the mosaic distribu-
tion of microglia in the CNS also appears to deteriorate. Microglia
in the aged mouse cortex are distributed less evenly than in the
young cortex; neighboring cells occasionally have somata that
are closely juxtaposed, instead of being evenly spaced and clearly
separated (Tremblay et al., 2012). In the healthy young retina,
microglia have an unique distribution as horizontally tiled arrays
that are limited only to the laminated inner layers of retina, with
no microglia found in the outer retinal layers (Santos et al., 2008).
With aging, this distribution pattern breaks down as microglia
translocate into the formerly “microglial-free” zone of the outer
retina and accumulate in the subretinal space (Xu et al., 2008;
Damani et al., 2011). The consequences of aging-related changes
in microglial distribution are not generally obvious; however in
the retina, this redistribution brings microglia into novel contact
with photoreceptors and retinal pigment epithelial (RPE) cells,
initiating immune changes in those cells that recapitulate patho-
logic phenotypes in AMD (Ma et al., 2009, 2012). Finding out
what drives age-related microglia redistribution may be thera-
peutically relevant to AMD treatment and prevention (Karlstetter
et al., 2010; Buschini et al., 2011). These studies comparing the
distribution of microglia in young and aged animals rely on
the ability of microglial markers such as Iba1 to consistently
reveal microglia across different ages. Although it is theoretically
possible that unknown subsets of microglia may change their
expression of these markers with aging to elude detection and
confound the results described, the stability of Iba1 expression
across aging (unpublished data) and different activation states,
makes this unlikely.
In addition, microglia undergo changes in their ramified
morphology with aging. In the mouse retina, aged microglia
demonstrate smaller dendritic arbors relative to young microglia
which are less branched and are have smaller total process
lengths (Damani et al., 2011). In the aging mouse cortex and
hippocampus, microglial dendritic arbors are similarly smaller,
more variable in size, less circularly symmetric, and more elon-
gated in shape (Sierra et al., 2007; Tremblay et al., 2012). In
aged human (but not in rodent) brains, sporadic microglial
cells have been observed to exhibit dystrophic morphologies in
which dendritic arbors appear deramified, with residual processes
showing increased tortuosity, cytoplasmic beading, and fragmen-
tation, reflective of ongoing cytorrhexis (Streit et al., 2004). As
microglial processes are constitutively dynamic structures whose
contact with surrounding cells mediate a host of functions includ-
ing immune surveillance (Nimmerjahn et al., 2005), synaptic
regulation (Wake et al., 2009; Tremblay et al., 2010; Schafer
et al., 2012), regulation of neuronal activity and neurogenesis
(Nakanishi and Wu, 2009; Nakanishi et al., 2011), these age-
related reductions in the structure of ramified processes are likely
to be functionally influential and indeed detrimental to the effi-
ciency of these functions. A summary of changes in microglial
distribution, morphology, and behavior associated with aging is
provided in Table 1.
AGING CHANGES IN BASAL STATES OF MICROGLIAL ACTIVATION
In addition to changes in anatomy, microglia demonstrates aging
changes in their immune physiology. Multiple lines of evidence
have indicated that microglia in the aged CNS show increased
basal states of activation. In histopathology studies of the aging
human brain,microglial morphologies exhibit a perinuclear cyto-
plasm hypertrophy and retracted processes, reminiscent of acti-
vated microglia (Sheng et al., 1998; Miller and Streit, 2007). Aged
microglial immunophenotypes also resemble those of activated
microglia, with increased expression of major histocompatibil-
ity complex II (MHCII) and CD11b (Rogers et al., 1988; Perry
et al., 1993; Frank et al., 2006; Ziv et al., 2006). Molecular markers
Table 1 | Summary of changes in microglial distribution, morphology, and behavior associated with aging.
Phenotypes
CHANGES IN MICROGLIAL DISTRIBUTION
Increase in microglial numbers/density in neural parenchyma
Decrease in regularity in distribution
Translocation into areas not previously occupied by microglia (e.g., to the outer layers of the retina)
CHANGES IN MICROGLIAL MORPHOLOGY
Decrease in individual microglial ramification (dendritic arbor area, branching, and total process length)
Appearance of morphological changes suggestive of increased activation state (e.g., perinuclear cytoplasmic hypertrophy, retraction of processes)
Sporadic appearance of dystrophic microglia in aged human brains
CHANGES IN MICROGLIAL DYNAMIC BEHAVIOR
Decrease in rate of process movement
Decrease in rate of migration to focal tissue injury
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typically found to be up-regulated in activated microglia activa-
tion (e.g., Iba1, OX6) are also increased in aged microglia in the
absence of injury or disease (Ogura et al., 1994; Frank et al., 2006).
In healthy aged humans, in vivo positron emission tomography
(PET) using R-[11C]PK11195 revealed increased ligand bind-
ing in several cortical and subcortical areas, indicating increased
levels of basal microglial activation (Schuitemaker et al., 2010).
Consistent with these markers of increased activation, aged
microglia are found to express increased levels of effector
molecules associated with activated microglia. Increased expres-
sion of inflammatory cytokines (such as IL1β, TNF-α, IL6) are
detected in aged microglia studied in situ (Sheng et al., 1998),
isolated ex vivo (Sierra et al., 2007; Njie et al., 2012), or when
cultured in vitro (Ye and Johnson, 1999). Interestingly, stud-
ies examining the levels of anti-inflammatory cytokines such
as IL10 are less uniform, with differing associations with aging
described in different studies (Ye and Johnson, 2001; Sierra et al.,
2007). On the whole, there is consensus on the increased acti-
vated basal state of microglia in healthy aging, indicating that
aged microglia may contribute to the graded chronic states of
“para-inflammation”(Medzhitov, 2008) that is associated with
the increased susceptibility of the aged CNS to neurodegenerative
diseases in which chronic neuroinflammation feature.
INFLUENCE OF AGING ON EVERYDAY FUNCTIONS
OF MICROGLIA
AGING MICROGLIA AND NEUROTROPHIC FUNCTIONS
Given the above descriptions for how microglia change in their
structural and basal activation state with aging, how can we
connect these aging phenotypes to potential changes in “every-
day” functions ofmicroglia? Concepts concerning the constitutive
functions of microglia in a healthy CNS have been changing and
developing in an exciting way over the last few years as key dis-
coveries reveal new functional roles. A number of metaphors
have arisen in the literature concerning these roles: microglia, for
their role in dynamic immune surveillance, have been likened
to “cops on the beat” (Raivich, 2005). For their role in con-
stitutive pruning and maintenance of synapses, they have been
named as “constant gardeners” (Hughes, 2012). Microglia also
appear to maintain a conducive environment in the CNS for the
healthy function and survival of neurons, prompting the descrip-
tion of “industrious housekeepers” (Streit and Xue, 2009). With
regards to the latter function, the presence of ramified microglia
have been associated with the provision of trophic support for
neurons; neuronal cell death in injury models increases with
maneuvers that result in the depletion of microglia (Montero
et al., 2009; Vinet et al., 2012). Conversely, repletion of microglia
or introduction of exogenous microglia result in neuronal rescue
in injury models (Kitamura et al., 2004; Imai et al., 2007), driven
possibly by microglial production of trophic influences such as
growth factors (Imai et al., 2007; Boscia et al., 2009), adenosine
(Lauro et al., 2010), TNF-α (Lambertsen et al., 2009), or via the
clearance of deleterious byproducts of neurotransmission (e.g.,
glutamate) (Persson et al., 2005; Persson and Ronnback, 2012)
and metabolism (e.g., iron and excess oligodendroglial mem-
brane) (Fitzner et al., 2011; Ward et al., 2011). As such, the
senescent debilitation of microglia, suggested by the emergence
of dystrophic, fragmented microglia in aged human brains, have
been associated with a decline of neuroprotective function, and
with it, an increased vulnerability of the CNS. Indeed, the so-
called “microglial dysfunction hypothesis” (Streit and Xue, 2009)
articulates that the age-related susceptibility to neurodegenera-
tive disease in human is causally connected to the age-related
microglial deficiency in neuroprotective function. In support of
this view, dystrophic microglia have been co-localized with areas
of neurodegeneration and tau pathology in Alzheimer’s brains
(Streit et al., 2009), indicating that neurodegeneration in these
examples follow from the failure of local support from senescent
microglia.
AGING MICROGLIA AND MAINTENANCE OF NEURONAL ACTIVITY
AND SYNAPSES
As the “constant gardener” of synapses, microglia in recent stud-
ies have been found to constitutively regulate synaptic struc-
ture and neuronal activity. The constant dynamic behavior of
microglial processes (Davalos et al., 2005; Nimmerjahn et al.,
2005) appears not to be a random, cell-autonomous feature but
are instead have their overall rate, extent, and direction regu-
lated and guided by neuronal activity (Fontainhas et al., 2011;
Li et al., 2012). These dynamic processes are observed to make
repeated contact with synaptic structures and influence synap-
tic stability and pruning in an activity-dependent manner (Wake
et al., 2009; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer
et al., 2012), potentially altering overall activity patterns in neu-
ronal networks (Pascual et al., 2012). Microglia are capable of
modulating the activity of neurons by directly contacting neu-
ronal somata with their processes, down-regulating the activity
of contacted neurons (Li et al., 2012). Taken together, these
forms of regulation seem to constitute a homeostatic mecha-
nism regulating overall levels of activity in the CNS; neurons
with greater levels of activity release the attractant ATP in an
activity-dependent manner via probenecid-sensitive pannexin-
1 channels (Fontainhas et al., 2011; Li et al., 2012), inducing
microglia to migrate and polarize their processes toward them,
and which are then reduced in their activity following microglial
contact.
Is this “gardening” function of microglia influenced by aging?
In our work, we have observed that aged microglia interest-
ingly decline in their dynamic motility of their processes and
in their migration rates through neural parenchyma (Damani
et al., 2011). These decrements may translate into less frequent
and extensive synaptic and neuronal contacts and prolonged
microglia response times. These may potentially be related to (1)
age-related changes in the structure and electrotonic properties
of dendrites and dendritic spines (Duan et al., 2003; Kabaso et al.,
2009; Morrison and Baxter, 2012) and (2) a decreased homeo-
static regulation of neuronal activity. Also, we had found that
microglia migration to sites of neural injury is slower to initiate
in aged animals—but once accomplished, microglial aggregation
tends to bemore sustained and less reversible. Dysregulated fluxes
of microglia can therefore result in more sustained imbalances
in activity homeostasis, and possibly contribute to differential
responses to excitotoxic damage observed in young versus aged
brains (Campuzano et al., 2008).
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AGING MICROGLIA AND ADULT NEUROGENESIS
An additional constitutive role that microglia play involves the
regulation of adult neurogenesis. It is known that adult neuro-
genesis diminishes with aging, driven perhaps by a declining pool
of the neural stem cells (Medrano et al., 2009; Encinas and Sierra,
2012), or a cell-autonomous loss of proliferative capacity in pre-
cursor cells (Kuhn et al., 1996). However, as microglia are capable
of influencing neurogenesis in vitro studies (Butovsky et al., 2006;
Walton et al., 2006; Cacci et al., 2008) and are associated with
altered neurogenesis in vivo studies (Ekdahl et al., 2003; Monje
et al., 2003), the contribution of aging microglia to this decrease
has been examined. In one study in which neurosphere formation
from dissociated hippocampus tissue was used as a measure of
neuronal precursor cell (NPC) activity, lower levels of neurogen-
esis was found in 9-month-old mouse hippocampal tissue relative
to 2-month-old tissue (Vukovic et al., 2012). While depletion of
microglia from hippocampal tissue did not alter neurogenesis at
2 months, it resulted in increased neurogenesis at 9 months, indi-
cating that microglia in the aged hippocampus, but not in the
young hippocampus, contribute to an age-related suppression of
NPC activity.
What controls the ability of microglia to influence neuroge-
nesis? The ability of aged microglial to limit neurogenesis has
been related to the increasing pro-inflammatory basal state of
aging microglia, in which pro-inflammatory mediators produced
by aged microglia can inhibit neurogenesis (Ekdahl et al., 2003;
McPherson et al., 2011). The connection between microglia and
neurogenesis is, however, complicated by findings that different
subtypes of microglia in the CNS may affect neurogenesis differ-
entially. Depletion of all microglia from dissociated hippocampi
of young, exercising mice reduces neurosphere formation in vitro,
suggesting that the entire population of microglia post-exercise
exerts a net positive contribution to neurogenesis (Vukovic et al.,
2012). However, depletion of only the Csf1r+MHCII+ subpopu-
lation of microglia conversely increased neurosphere formation,
indicating that this subset may instead hold back neurogenesis.
These results present the possibility that subpopulations of pro-
and anti-neurogenesis microglia change in their representation as
a function of aging and may differentially regulate neurogenesis
in different brain areas. Also, microglial effects on neurogenesis
may also be modulated by signals in the aging brain environ-
ment. CX3CL1-CX3CR1 signaling in particular appears influ-
ential in conferring on microglia their pro-neurogenesis effects
(Bachstetter et al., 2011). CX3CL1 levels in the aged hippocampus
were found to decline in concert with decreasing rates of neuro-
genesis. Revealingly, exogenous CX3CL1 application was found
to increase neurogenesis, and is effective only in the presence of
microglia (Bachstetter et al., 2011; Vukovic et al., 2012).
The types of communication occurring between microglia and
neural precursor cells (NPC) are not fully understood. Microglia
can influence NPCs via secreted factors that direct their migra-
tion and differentiation (Aarum et al., 2003; Walton et al., 2006).
These may occur either by direct signaling or by modifying
the microenvironment of the neurogenic niche (Battista et al.,
2006). Alternatively, microglia can physically interact with neu-
ral precursors by direct contact, influencing neurogenesis by
phagocytosis of apoptotic newborn neurons (Sierra et al., 2010).
However, this form of microglial phagocytosis appears unaffected
by aging or by microglial activation, further reflecting a nuanced
relationship between microglial function and neurogenesis.
INFLUENCE OF AGING ON MICROGLIA RESPONSES
TO PERTURBATIONS
In the above sections, we have largely considered how the aging
phenotype in microglia influences their functions in a healthy
uninjured CNS. The question that is considered in this sec-
tion concerns how aging in microglia influences their ability to
respond appropriately to perturbations such as injury, infections,
or disease. The classic notion concerning microglial response to
perturbation is the acquisition of an activated state. Microglia
demonstrates a particular activation status that is a function
of the balance of extrinsic signals in their milieu (Hanisch
and Kettenmann, 2007). These signals are composed of either
“On” signals that induce greater activation, or “Off” signals that
induces the maintenance of, or a return to, a resting basal state
(Van Rossum and Hanisch, 2004; Biber et al., 2007). Also relevant
to this picture are intrinsic, cell-autonomous factors and mech-
anisms within microglia that influence and limit the magnitude
and duration of activation responses. While these mechanisms
have not been fully characterized, they include nuclear recep-
tor signaling (Saijo et al., 2011, 2013) and microRNA-regulated
gene expression (Ponomarev et al., 2013). Optimal microglial
responses to perturbation comprise of a rapid, pro-inflammatory
activation, necessary to produce efficient responses to injury and
infections, as well as a well-timed and expeditious resolution of
activation, required to avoid sustained damage to the CNS.
There is accumulating evidence that microglial responses to
CNS perturbations become more dysregulated with aging. In the
aged brain, in addition to the mild increases in basal microglial
activation, microglia demonstrates increased priming or sensi-
tization, and as a result generates responses to inflammatory
stimuli that are exaggerated and prolonged. In numerous stud-
ies involving animal models of infectious and inflammatory
challenge (Sparkman et al., 2005; Sierra et al., 2007; Abraham
et al., 2008; Barrientos et al., 2009a,b; Norden and Godbout,
2012), hemorrhagic stroke (Wasserman and Schlichter, 2008;
Wasserman et al., 2008), cognitive and physiological stressors
(Buchanan et al., 2008; Rosczyk et al., 2008), and neurologi-
cal injury induced by axotomy (Conde and Streit, 2006), neu-
rotoxins, (Sugama et al., 2003) or trauma (Sandhir et al.,
2008), responses generated in aged animals tend in general to
be larger and more sustained, and culminate in more severe
anatomical degeneration and functional debilitation relative to
those produced in young animals. These larger inflammatory
responses appear to be causally related to increased neuro-
logical deficits; in studies involving E. coli- and lipopolysac-
charide (LPS)-induced systemic infection in aged mice, inhi-
bition of IL-1β signaling blocked both the neuroinflamma-
tory response as well as the associated cognitive deficits (Frank
et al., 2010; Barrientos et al., 2012). Augmented neuroinflam-
matory responses are thought to suppress growth factor signal-
ing, particularly that involving BDNF (Barrientos et al., 2004;
Chapman et al., 2012), which is directly associated to neurological
dysfunction.
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What mechanisms result in age-related priming of microglia?
An altered balance of “On” vs. “Off” extrinsic signals in the
aging brain milieu, as well as the altered reception of these sig-
nals by microglia, constitute potential mechanisms. Microglial
expression of pattern recognition receptors (PRRs) such as TLR1,
TLR2, TLR4, TLR5, TLR7, and CD14 are up-regulated with
increasing age (Letiembre et al., 2007). “Off” signaling involving
CX3CL1-CX3CR1 and CD200-CD200R signaling also undergoes
aging changes as the expression levels of “Off” ligands, CX3CL1
(Bachstetter et al., 2011) and CD200 (Frank et al., 2006; Lyons
et al., 2007), as well as “Off” receptor CX3CR1 (Wynne et al.,
2010), all decrease with advancing age. These reductions in “Off”
signaling in aged microglia may be the basis for a more chronic
activation and prolonged pro-inflammatory responses, a phe-
notype that is milder but mechanistically similar to the more
pronounced pro-inflammatory effects observed in CX3CR1- and
CD200-knockout mouse models (Hoek et al., 2000; Corona et al.,
2010). The ability of exogenous CX3CL1 to reverse phenotypes
associated with microglial aging (decreased neurogenesis, acti-
vated immunophenotype) also underscore its involvement as a
driver of age-related priming of microglia (Bachstetter et al.,
2011).
ATP signaling via purinergic receptors on microglia surfaces
may also contribute to aging-related responses. It has been found
that microglial responses to local tissue injury in the forms
of increased process dynamism and polarization and directed
migration are mediated by the local release of ATP as an injury
signal (Davalos et al., 2005; Farber and Kettenmann, 2006; Haynes
et al., 2006). In previous work, we found that dynamic microglial
responses to the changes in ATP concentrations in the envi-
ronment are age-related (Damani et al., 2011). As different P2
purinergic receptors have been described to vary with age (Crain
et al., 2009; Damani et al., 2011), changes in the reception of ATP-
related signals by microglia may contribute to changing dynamic
responses in aging microglia.
WHAT ARE SOME DRIVERS OF MICROGLIAL SENESCENCE?
What mechanisms result in the development of senescent phe-
notypes in microglia? A number of theories have been proposed
(summarized in Table 2). One theory invokes age-related replica-
tive senescence, which refers to the finite capability of cells to
undergo repeated cycles of replication. Microglia may undergo
low levels of replication under steady state conditions (Lawson
et al., 1992) and can proliferative quickly in response to perturba-
tions (Ajami et al., 2007). In the course of a lifetime, these cycles
can culminate in the shortening of telomeres and the attainment
of replicative senescence (Olovnikov, 1996). Microglia induced
to replicate in vitro do in fact demonstrate progressive telom-
ere attrition (Flanary and Streit, 2004), and telomere lengths in
microglia are shorter in aged compared to young brains (Flanary
et al., 2007). Levels of telomerase, an enzyme that can extend the
length of telomeres, also decrease inmicroglia with age, indicating
that aging microglia cannot as successfully re-lengthen telomeres
following injury-activated replication (Flanary and Streit, 2005).
While replicative senescence in microglia may constrain their
ability to go on proliferating, how it can drive the emergence of
other senescent microglial phenotypes is unclear.
Alternately, microglia aging may result from the accumulation
of biological changes that build up within microglia as a conse-
quence of physiological activities sustained over time. Microglia
in the aged brain accrue prominent amounts of autofluorescent
lipofuscin (Sierra et al., 2007; Tremblay et al., 2012), that appears
on ultrastructure studies as lysosomal inclusions (Peinado et al.,
1998; Tremblay et al., 2012). Aged retinal microglia located in
the subretinal space also demonstrates autofluorescent lipofus-
cin granules which increase in number with age (Xu et al.,
2008). This intracellular accumulation is thought to result from
microglia phagocytizing lipofuscin or its precursor molecules
from nearby cells; autofluorescent granules found in subretinal
microglia have similar spectral characteristics as those found in
adjacent RPE cells, suggesting their common origin. Age-related
lipofuscin buildup in microglia may indeed be influential on
microglial physiology. In recent work, we found that cultured
retinal microglia accumulating A2E, a prominent component of
ocular lipofuscin, (1) developed a less ramified and more acti-
vated morphology, (2) demonstrated changes in gene expression
that favored a more pro-inflammatory profile with an increased
M1/M2 polarization, and (3) exhibited changes in the expression
of complement regulatory proteins that promoted increased com-
plement activation(Ma et al., 2013), all of which correspond to the
basal state of increased activation typical in senescence.
Another candidate mechanism invokes the concept of oxida-
tive stress. Microglia are prominent producers of oxidative
products including reactive oxygen species (ROS) in the CNS.
Mitochondria-derived ROS are produced in close proximity to
mitochondria DNA (mtDNA) which encode components of the
mitochondria electron transfer complexes. In aged microglia,
mtDNA damage accumulates and leads to dysfunction in the res-
piratory chain and an over-production of ROS (Corral-Debrinski
et al., 1992; Lin et al., 2002). Concurrently, decreased microglial
autophagy due to age-related accumulation of lipofuscin slows
down the turnover of senescent mitochondria, adding to the
increase in oxidative stress within microglia (Kurz et al., 2008).
As the activation of NF-κB mediated transcription in microglia,
Table 2 | Summary of proposed drivers of microglial senescence.
Drivers Effects
Shortening of telomeres Induction of replicative senescence and decreased ability to proliferate
Accumulation of intracellular lipofuscin Decreased autophagy, leading to decreased organelle (e.g., mitochondria) turnover, increased ROS
production, increased microglial activation
Accumulation of mtDNA mutations Dysfunction in respiratory chain and over-production of ROS, leading to increased microglial activation
Increased iron load Increased intracellular iron leads to increased ROS production and microglial activation
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which regulates the expression of multiple pro-inflammatory
cytokines, is positively modulated by ROS (Toledano and
Leonard, 1991), this increased redox state may serve to prime
microglia responses to perturbations, resulting in augmented
microglial activation states observed in agedmicroglia (Nakanishi
et al., 2011).
The age-related increase of oxidative stress as a driving force
for microglia senescence has also been related to iron manage-
ment in aging microglia. Levels of iron, and its storage protein,
ferritin, increase with age in brain tissues (Benkovic and Connor,
1993; Bartzokis et al., 1997; Kwan et al., 2012). Microglia, which
express ferritin, are thought to play a role in iron homeostasis
(Kaneko et al., 1989; Cheepsunthorn et al., 1998; Widmer and
Grune, 2005). As the iron load managed by microglia increases
in the aging brain, the risk of oxidative damage to microglia
increases as the labile nature of intracellular Fe2+ can readily lead
to the formation of ROS. Microglial activation with LPS has been
shown to increase ferritin expression in microglia and total iron
content in brain areas (Hunter et al., 2008). The related natures
of increased iron load, ROS production, and increased activa-
tion can potentially drive a feed-forward process that accelerates
the formation of senescent microglial phenotypes. Indeed, dys-
trophic microglia in aged brains, as well as those with Alzheimer’s
and Huntington’s disease, have been associated with ferritin
immunopositivity and accumulation (Simmons et al., 2007;
Lopes et al., 2008), suggesting a link between increased iron load
and the development of dystrophy in individual microglial cells.
CAN MICROGLIA BE REJUVENATED?
A discussion of the roles of microglial senescence in brain aging
and susceptibility to age-related neurodegeneration leads natu-
rally to the question of whether it is possible to prevent or reverse
the aging phenotypes of microglia. Proposed mechanisms for the
etiology of microglial senescence and the descriptions of senes-
cent microglial phenotypes present opportunities to formulate
therapeutic strategies for achieving this, as well as outcome mea-
sures for which these therapies can be assessed. A number of
these therapeutic approaches has been discussed or investigated
in the literature and are listed thematically in the sections below
(Table 3). Although there is currently a dearth of preventative
therapies for age-related neurological diseases, research aimed
at microglial “rejuvenation” may constitute a fruitful strategy in
generating these in the future.
ANTI-INFLAMMATORY AND ANTI-OXIDANT APPROACHES
The pro-inflammatory and primed characteristics of the aging
microglia phenotype prompt the use of an anti-inflammatory
approach to alleviate the consequences of microglial aging.
Minocycline, a highly bioavailable tetracycline-derived antibi-
otic with anti-inflammatory properties (Yrjanheikki et al., 1998,
1999; Tikka et al., 2001), has been investigated as an inhibitor of
microglial activation in numerous animalmodels of neuroinflam-
mation and CNS injury (Kim and Suh, 2009). Specific to its effect
on aging microglia, minocycline has been shown to ameliorate
pro-inflammatory cytokine production and sickness behavior
Table 3 | Proposed therapeutic approaches for the rejuvenation of senescent microglia.
Approaches Effects
ANTI-INFLAMMATORY AND ANTIOXIDANT APPROACHES
Minocycline Inhibits microglial activation, decreases microglial proinflammatory
cytokine production
IL1RA Inhibits IL1β-mediated proinflammatory signaling
Dietary supplementation with antioxidants: flavonoids (e.g., luteolin,
quercetin, genistein, hesperetin), retinoids/carotenoids (e.g., astaxanthin,
crocin, crocetin, retinoic acid, lutein, zeaxanthin), vitamins (E and D3)
Exerts antioxidant and anti-inflammatory effects, decreases markers of
neuroinflammation
PREVENTING OR REVERSING MICROGLIAL “RUN-DOWN” IN AGING
Decreasing lipofuscin accumulation with visual cycle modulators
(ACU-4429, fenretinide)
Partially inhibits the visual cycle to decrease ocular lipofuscin formation
in retinal microglia
Stimulation of microglial autophagy (e.g., anti-lipolytic drugs, rapamycin) Increases autophagy to promote mitochondria turnover in microglia
Stimulation of TFAM expression or activity (e.g., resveratrol, brimonidine) Inhibits accumulation of mtDNA mutations in microglial mitochondria,
decreasing ROS production
MODULATION OF THE AGING MICROGLIAL MILIEU
Stimulation of CX3CL1-CX3CR1 signaling Decreases microglial activation states
Stimulation of CD200-CD200R signaling [stimulation of IL4 signaling,
fibroblast growth loop (FGL)]
Decreases microglial activation states
Exercise Decreases microglial activation states, up-regulates proliferation of
neural precursor cells
REPLACEMENT OF AGED MICROGLIA
Depletion, followed by autologous or exogenous repletion by bone marrow
derived cells
Enables the replacement of endogenous aged microglia with
“replacement” immune cells that can carry out microglial functions
Cell-based therapies involving stem cells Enables the replacement of endogenous aged microglia with
“replacement” immune cells that can carry out microglial functions
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following LPS-administration in aged mice (Henry et al., 2008)
and to reduce aging-exacerbated deficits in long-term poten-
tiation (LTP) in the aged rat hippocampus (Griffin et al.,
2006; Liu et al., 2012). Clinical studies involving the use of
minocycline for neurodegenerative diseases are ongoing; results
of completed studies have produced both positive and nega-
tive results in separate disease contexts, revealing the need for
further investigations (Plane et al., 2010). In contrast to minocy-
cline, which has broad and somewhat varied anti-inflammatory
actions, specific and targeted therapeutic approaches have also
been considered. The central role of IL1β in mediating age-related
pro-inflammatory effects of microglia has led to investigations
of the IL1 receptor antagonist, IL1RA, as a potential ther-
apy. Administration of IL1RA was found to ameliorate deficits
in long term memory (Frank et al., 2006), impairments in
theta-burst late-phase LTP (Chapman et al., 2010), and sick-
ness behavior (Abraham and Johnson, 2009a) following immune
challenges by E. coli or LPS administration. These findings
may prompt future clinical investigations involving approved
inhibitors of IL-1 signaling (anakinra, rilonacept, canakinumab)
for the treatment of neurodegenerative disease (Dinarello et al.,
2012).
As the generation of ROS and increased oxidative stress has
been associated with the activation of pro-inflammatory pro-
grams in primed microglia (Verri et al., 2012), anti-oxidant
approaches involving the use of dietary compounds have been
examined inmultiple studies, with the goal of reducingmicroglial
activation in the course of reducing oxidative stress (McGahon
et al., 1999; Gemma et al., 2002; Abraham and Johnson, 2009b).
Flavonoids, a class of plant phenolics found widely in a vari-
ety of fruits, vegetables, and grains, have been investigated in
the forms of luteolin, quercetin, genistein, hesperetin, among
others, and have been found to decrease markers of neuroin-
flammation (Jang and Johnson, 2010; Izzi et al., 2012). Dietary
administration of luteolin, one of the more potent agents in this
regard (Comalada et al., 2006), decreased inflammatory markers
and improved spatial working memory in aged mice (Jang et al.,
2008, 2010). Dietary components of the retinoid/carotenoid class
(which include astaxanthin, crocin, crocetin, retinoic acid, lutein,
zeaxanthin, and their synthetic derivatives) have also been found
to decrease microglia and macrophage activation in numerous
in vitro studies (Dheen et al., 2005; Xu and Drew, 2006; Kim
et al., 2008, 2010; Nam et al., 2010; Bian et al., 2012). Anti-oxidant
supplements such as alpha-tocopherol (Vitamin E) (Murray and
Lynch, 1998; Berg et al., 2005) and vitamin D3 (Moore et al.,
2005) have been found to exert anti-inflammatory benefits. While
the combination of in vitro, animal model, and epidemiolog-
ical studies indicates the promise of dietary supplementation,
verification of benefit in large scale controlled clinical studies
is a necessary next step. Currently, there are few therapies of
this nature that have been proven and approved for age-related
neurodegenerative disease. One exception is AMD, a disease in
which activated microglia in the aged retina feature (Gupta et al.,
2003; Ma et al., 2013), for which anti-oxidant supplementa-
tion with vitamin A, C, E, and zinc, constitutes the current
standard of care in reducing risk for disease progression (Age-
Related Eye Disease Study Research, 2001). Results for a large
scale trial involving supplementation with the carotenoids, lutein
and zeaxanthin, and omega-3 fatty acids, for preventing AMD
progression are expected in mid-2013 (AREDS2 Research Group
et al., 2012).
PREVENTING OR REVERSING MICROGLIAL “RUN-DOWN” IN AGING
The concept that aging microglia accumulate progressive phys-
iological changes (build-up of lipofuscin, increasing number of
mtDNA mutations) that drive the emergence of senescent phe-
notypes suggest the feasibility of strategies that aim to amelio-
rate or reverse these changes. Measures targeted at lipofuscin
accumulation in microglia may help alleviate lysosomal dysfunc-
tion, increase autophagy, decrease ROS production, and in gen-
eral, ameliorate the detrimental phenotypes of aging microglia
(Nakanishi and Wu, 2009). In the retina, lipofuscin accumu-
lates in microglia of aged and AMD retinas (Ma et al., 2013)
and is compositionally akin to that accumulating in nearby RPE
cells (Xu et al., 2008). Current clinical studies of visual cycle
modulators (ACU-4429, fenretinide) (Kubota et al., 2012; Mata
et al., 2012) that aim to decrease lipofuscin accumulation in
RPE cells may also be helpful in decreasing accumulation in reti-
nal microglia. Alternatively, measures that stimulate autophagy,
a process slowed by lipofuscin accumulation, may also be help-
ful. Anti-lipolytic drugs and rapamycin, which are agents found
increase autophagy (Donati, 2006; Cai et al., 2012), have also
been associated with reductions in age-related oxidative damage
(Donati et al., 2006; Yang and Ming, 2012) and microglial activa-
tion (Dello Russo et al., 2012), and may therefore be useful in the
therapy of neurodegenerative disease (Chong et al., 2012). Early
stage clinical trials have been conducted with rapamycin for AMD
and multiple sclerosis (NCT00095329 and 00766649) but results
are not currently available.
With respect to the age-dependent accumulation of mtDNA
mutations in aged microglia, a nucleus-encoded protein called
transcription factor A, mitochondrial (TFAM) has been found
to promote mtDNA transcription and maintain its architectural
structure (Kanki et al., 2004). TFAM overexpression can reduce
ROS production and NF-κB activation in vitro and decrease age-
related mtDNA damage and IL1β expression in hippocampal
microglia in vivo (Hayashi et al., 2008). As a result, compounds
that can stimulate TFAM expression or activity, such as resvera-
trol (Lagouge et al., 2006; Vetterli et al., 2011) and brimonidine
(Lee et al., 2012a) may be useful in this strategy.
MODULATION OF THE AGING MICROGLIAL MILIEU
The increased basal inflammatory state and priming in aged
microglia that result from an age-dependent shift in balance
between “On” and “Off” signals may be another target for
microglial “rejuvenation.” During aging, the expression levels of
“Off” ligands CX3CL1 and CD200 decrease concurrently with
increases in microglial activation status; the causal influence
of these changes are demonstrated by the ability of exogenous
CX3CL1 or a CD200 fusion protein to ameliorate phenotypes
associated with microglial aging (Lyons et al., 2007, 2009a,b; Cox
et al., 2012; Vukovic et al., 2012). These results present these
signaling pathways as promising molecular targets for interven-
tion. For the CX3CL1-CX3CR1 signaling axis, despite increasing
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attention in different disease areas, suitable modulatory agents
have yet to be investigated in clinical studies (D’Haese et al.,
2012). For the CD200-CD200R axis, measures that increase IL4
(phospholipid microparticles-incorporating phosphatidylserine,
atorvastatin), which up-regulates CD200 expression, can improve
age-related decreases in LTP attributed to microglial aging (Nolan
et al., 2005; Lyons et al., 2007, 2009b, 2011; Clarke et al., 2008).
Also, a neural cell adhesion molecule (NCAM)-derived peptide,
FGL, which can increase CD200 expression in vitro and in vivo,
has been found to abrogate age-related increases in glial activa-
tion and synaptic changes (Downer et al., 2009, 2010; Ojo et al.,
2012). Discovery of other “Off” signaling pathways can augment
this strategy of modulating the milieu of aging microglia in ways
that promote microglial quiescence.
EXERCISE
Physical exercise has been associated with a number of salubri-
ous effects on CNS in animal studies, including increasing adult
neurogenesis, improving performance on cognitive tasks, and
ameliorating various declining neurological parameters observed
with aging (Van Praag et al., 1999, 2005; Kim et al., 2004;
Blackmore et al., 2009). Also, exercise has been implicated in
improving aspects of systemic immune function (Woods, 2005).
Recent studies have connected these two classes of effects in show-
ing that exercise may exert its effects on the CNS, at least in
part, through the modulation of microglia activity. The exagger-
ated neuroinflammatory response following a peripheral immune
challenge in aged animals, which is associated with increased
cytokine production, reduced BDNF expression, and increased
cognitive deficits, was found to be completely reversed by vol-
untary exercise (Barrientos et al., 2011). This effect of exercise
appears to be mediated by the “de-priming” of aged microglia as
microglia from isolated the brains from exercising mice similarly
demonstrated a more modest pro-inflammatory response to LPS
administered in vitro relative to those from non-exercising mice.
In a separate study, exercise was found to promote adult neuro-
genesis by stimulating greater NPC proliferation (Vukovic et al.,
2012). These effects again appear to be mediated via microglia as
prior depletion of microglia completely eliminates them. In this
study, exercise seems to influence microglia through increased
expression of CX3CL1, which confers on microglia the ability
to up-regulate NPC proliferation. In other studies, exercise in
animals was found to decrease age-related basal microglial prolif-
eration (Kohman et al., 2012), and to lower microglial activation
in models of hypoxia (Lin et al., 2012), high-fat diet (Yi et al.,
2012), tau overexpression (Leem et al., 2011), and closed-head
injury (Chen et al., 2012), further supporting the notion that exer-
cise can play a role in deactivating and de-priming microglia. The
molecular mechanisms underlying how exercise mediates these
effects will be a fascinating area for future study, andmay discover
agents that can elicit exercise-induced effects without the need for
actual exercise.
REPLACEMENT OF MICROGLIA AS THERAPY?
Although microglia are long-lived residents of the CNS and are
not readily turned-over in the uninjured CNS, it remains plausi-
ble that aged microglia, instead of being modulated, may actually
be wholly replaced or reinforced by exogenously introduced cells
capable of carrying out the functions of young, non-senescent
microglia. Studies in organotypic hippocampal slice cultures have
shown that brain slices deprived of microglia can be again replen-
ished by exogenously introduced cultured microglia which are
able to colonize the brain parenchyma, acquire a ramified mor-
phology, and confer neuroprotection to excitotoxic injury (Vinet
et al., 2012). Animal studies have demonstrated that lethal irradi-
ation followed by bone marrow transplantation allows the elim-
ination of endogenous microglia and their replacement by bone
marrow-derived cells which acquire features of microglia within
the CNS parenchyma (Simard and Rivest, 2004). This technique
of “microglial replacement” has enabled microglia expressing a
mutant version of a particular gene in a transgenic mouse to
be replaced by wild type microglia expressing a functional ver-
sion of the same gene. These microglial “replacements” have been
successful in alleviating the neurological and systemic symptoms
in MECP2 mutant mice, a model for Rett syndrome (Derecki
et al., 2012), in correcting abnormal grooming behavior inHoxb8
mutant mice, a possible model for obsessive-compulsive disor-
der (Chen et al., 2010), and in increasing survival in SOD1G93A
transgenic mice, a model for amyotrophic lateral sclerosis (ALS)
(Lee et al., 2012b). Conversely, replacement of wild type microglia
with transgenic microglia deficient inMyD88 signaling was found
to increase disease susceptibility in amouse ALSmodel (Kang and
Rivest, 2007). Even in the absence of bone-marrow transplanta-
tion, the depletion of brain microglia has been found to induce
an influx of peripheral monocytes into the CNS that repopulates
the microglia-depleted areas (Varvel et al., 2012). These “replace-
ment” cells intriguingly resemble endogenous microglia in dis-
tribution, morphology, and physiology, suggesting the notion
that worn-out, aged brain microglia can perhaps be replaced by
fresher and more able recruits from the periphery. The possibility
that we can harness our intrinsic capability to “self-rejuvenate”
our CNS microglia using our peripheral immune system is a
radical but tantalizing concept.
The ability of microglia to be replenished in the CNS by
peripherally derived cells that can take on features and functions
of microglia present the possibility that these approaches may
be in the future be translated into cell-based therapies to reju-
venating the population of senescent microglia in aged brains.
Further studies still remain to be done regarding (1) possi-
ble sources of replacement cells (including stem cells sources)
(Selvaraj et al., 2012), (2) the physiological functioning of
newly integrated cells in an aged brain milieu, and (3) the
use of brain conditioning regimens to optimize the spatial and
temporal extents of microglial replacement (Capotondo et al.,
2012) in order to increase and to realize the feasibility of such
strategies.
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